ABVC BioPharma, Inc. (ABVC)
0.87
+0.01
(+1.46%)
USD |
NASDAQ |
Sep 01, 10:01
ABVC BioPharma Total Long Term Debt (Quarterly) : 1.406M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.406M |
| March 31, 2026 | 1.511M |
| December 31, 2025 | 1.601M |
| September 30, 2025 | 0.1641M |
| June 30, 2025 | 0.1771M |
| March 31, 2025 | 0.167M |
| December 31, 2024 | 0.2368M |
| September 30, 2024 | 0.1422M |
| June 30, 2024 | 0.2288M |
| March 31, 2024 | 0.3182M |
| December 31, 2023 | 0.4075M |
| September 30, 2023 | 2.161M |
| June 30, 2023 | 3.909M |
| March 31, 2023 | 3.918M |
| December 31, 2022 | 0.7918M |
| September 30, 2022 | 0.8802M |
| June 30, 2022 | 0.9443M |
| March 31, 2022 | 1.034M |
| September 30, 2021 | 1.316M |
| June 30, 2021 | 4.036M |
| March 31, 2021 | 4.120M |
| December 31, 2020 | 4.331M |
| September 30, 2020 | 2.156M |
| June 30, 2020 | 2.305M |
| March 31, 2020 | 2.191M |
| Date | Value |
|---|---|
| December 31, 2019 | 2.256M |
| September 30, 2019 | 1.886M |
| June 30, 2019 | 1.166M |
| March 31, 2019 | 1.085M |
| December 31, 2018 | 0.8551M |
| September 30, 2018 | 0.55M |
| June 30, 2018 | 0.55M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 1.138M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 23.32M |
| Perspective Therapeutics, Inc. | 2.866M |
| MiMedx Group, Inc. | 17.21M |
| Abbott Laboratories | 32.61B |
| AngioDynamics, Inc. | 9.66M |